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Introduction 
Chloramine-T, a potent disinfectant has been used 
to clean surfaces in butcheries, kitchens, operating 
rooms, laboratories and dairies. In 1945, Feinburg 
and Watrous (1) found occupational asthma and 
rhinitis in workers exposed to chloramine-T. The 
diagnosis was based on wheal and flare skin reactions 
to chloramine-T. So far, chloramine-T allergy has 
only been described in subjects who have been in 
contact with the powder of the disinfectant. To our 
knowledge, this report is the first to describe the 
provocation of occupational asthma by aerogenic 
exposure to commercial chloramine-T solution. 
Case Report 
A 36-year-old non-atopic female cleaner who had 
never smoked regularly presented with sneezing, 
bronchial coughing and dyspnoea a few months after 
she started to use a new disinfectant at work. The 
respiratory symptoms appeared immediately after the 
exposure to chloramine-T and continued several 
hours after the working shift. The symptoms 
disappeared when she had to stay out of work. 
At work, she cleaned showers and saunas at a 
municipal indoor swimming pool. Chloramine-T 
(Alinex’*) was mainly used in a 10% solution 
(10 mg ml ~ ‘) and the worker sprayed the disinfect- 
ant on the walls and floors with pressurized water. 
The temperature in the working environment was 
30°C and the relative humidity of the tidal air was 
50-80% although there was mechanical extract 
ventilation in the room and the extracted air rate was 
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up to 6.2dm3s-‘m-* of the floor. PEF values 
decreased from baseline 470 1 min - ’ to 400 1 min - ’ 
(15%) at work. 
In the clinical examination, chest ausculation 
was normal. Leucocyte count was 4.500 with 2.5% 
eosinophils. Total serum IgE was 151 IU 1 - ’ and 
the specific IgE to chloramine-T was 16.27 IU 1 - ’ 
(Pharmacia Diagnostics, Uppsala, Sweden). Skin 
prick tests with common inhalant allergens were 
negative. Skin prick test with chloramine-T solution 
(0.5 mg ml ~ i showed an immediate wheal and flare 
reaction which was as large as the reaction caused by 
1% histamine dihydrochloride (used as a positive 
control). Chest radiograph was normal. In lung func- 
tion tests, forced vital capacity (FVC) was 4.43 1 
[109% of predictive value (2)], FEV, was 3.15 1(91%) 
and FEV% was 71%. Histamine provocation test 
revealed symptoms of moderate bronchial hyper- 
reactivity, and the provocative dose of histamine 
diphosphate which induced a 15% fall in FEV, was 
0.18 mg. 
Bronchial provocation was performed by using 
a Spira Elektro 2R’ dosimeter (3) (Hengitys- 
hoitokeskus, Hameenlinna, Finland). First the 
patient inhaled saline as placebo which did not 
significantly change PEF values over 24 h. The 
chloramine provocation was performed using a single 
inhalation of chloramine-T solution (0.5 mg ml - ‘) 
with a Spira Elektro 2@ dosimeter. In this automatic 
inhalation-synchronized dosimeter, aerosol delivery 
time was adjusted to 0.2 s and the threshold volume 
of inspiration to 100 ml. The provocative dose of 
chloramine-T was 2,Opg. After 15 min, the patient 
developed rhinorrhea, coughing, dyspnoea and bron- 
chial wheezes. In spirometry (Fig. l), FEV, decreased 
from 3.05 1 to 1.65 1 (46%) and PEF values decreased 
from 475 1 min ~ ’ to 295 1 min - ’ (38%). Symptoms 
disappeared and PEF values returned to normal 
within 3 h of administration of inhaled broncho- 
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Fig. I The results of pulmonal functions (PEF and 
FEV,) after one inhalation of chloramine-T solution 
(0.5 mg ml- ‘) with Spira Elektro 2’R’ dosimeter. 0, PEF; 
0, FEV,. 
dilator. Between 4-10 h after inhalation, the patient 
experienced dyspnoea again, accompanied by wheez- 
ing. A fall in PEF values of 43% of the pre-inhalation 
value reoccurred. FEV, was not measured during 
the late reaction. Arterial blood oxygen pressure was 
decreased to 7.85 kPa. Pulmonary diffusing capacity 
was normal and chest radiograph showed no abnor- 
malities. Leucocyte and eosinophil counts in blood 
remained normal. 
A diagnosis of chloramine-T-induced occupational 
asthma was confirmed on the basis of positive skin 
prick test, RAST, bronchial provocation test results, 
adequate workplace exposure, and onset of 
work-related asthmatic symptoms. 
Discussion 
Chloramine-T is a water soluble powder with 
potent oxidizing, anti-viral, bactericidal and fungi- 
tidal properties. A chloramine-T powder has previ- 
ously been reported to cause occupational asthma 
(1,4,6,7). In 1979, Bourne et al. (4) provided evidence 
that these asthmatic symptoms were of allergic origin 
and soon after, Kramps et al. (5) demonstrated that 
the asthmatic reaction was due to specific IgE- 
meditated reactions caused by chloramine-T. In 198 1, 
Dijkman et al. (6) were able to show that the bron- 
chial obstruction due to chloramine-T can be either 
an immediate (develops l&20 min after exposure) or 
late onset type of reaction (develops 68 h after 
exposure). The antigenic determinant responsible for 
the immunological reaction has been suggested to be 
formed by the para-toluenesulfonyl group of the 
chloramine-T molecule (5). 
In this case report, the previously healthy cleaner 
developed an immediate and late bronchial obstruc- 
tion after the exposure to chloramine-T solution. She 
had asthmatic symptoms during and after the work- 
ing shift. No bronchial wheezing on chest auscul- 
tation was detected during the first clinical 
examination. After the provocation test, however, the 
patient developed severe dyspnoea the duration of 
which was longer than was expected. The dose of 
chloramine-T used in the provocation test was 
selected according to previous studies (6) and the 
solution was inhaled by Spira Elektro 2@ dosimeter. 
In addition, the chloramine-T concentration used in 
the inhalation challenge test was assumed to corre- 
spond to the chloramine-T exposure at the working 
place. According to our experience in this case, 
however, the provocation test should be started with 
a solution containing 0.05 mg ml - ’ of chloramine-T 
and if an immediate reaction does not occur, provo- 
cation could be continued with a solution of 
0.5mgml-‘. 
In earlier studies, specific IgE antibodies to 
chloramine-T have been detected in patients’ sera. On 
the contrary, specific IgG antibody isotypes have not 
been associated with chloramine-T allergies (5). In 
this report, the patient had an increased total serum 
IgE and specific IgE to chloramine-T. 
The patient in this case report had respirat- 
ory symptoms soon after she started to use 
chloramine-T solution as a disinfectant. The work- 
ing environment where she did the cleaning was 
equipped with a mechanical extract air ventilation 
system. The artificial ventilation was insufficient to 
impede the hazardous increase in the concentration 
of the aerosolized and vaporized allergen in the 
room air. Especially at the time of spraying, with 
the allergenic solution in humid and warm working 
conditions, the health hazard is obvious. It is 
unknown what the sufficient air change rate is in 
purpose to avoid sensitization during disinfection in 
special environments. A non-sensitizing solution 
should be used in such cleaning work to avoid 
allergic disorders. 
In conclusion, chloramine-T which is used as a 
potent disinfectant may cause a health hazard to 
cleaners who are exposed to chloramine-T aerosol. 
After aerogenic exposure to chloramine-T solution, 
the risk of developing hypersensitivity reactions, 
rhinitis and bronchial asthma is increased. 
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